#pharmaceuticals

[ follow ]
#stock-market

Pharma shares hit as Trump picks RFK Jr to lead health department

Trump's nomination of Robert F Kennedy Jr as Health Secretary has triggered panic selling among pharmaceutical investors.

S&P 500 and Dow notch new records

The U.S. stock market saw record highs due to tech and pharmaceutical stock increases.

Pfizer stock surges after activist takes $1 billion stake

Pfizer's stock peaked during the pandemic but has faced significant losses as demand for COVID-19 products faltered.

Eli Lilly (LLY) Stock Price Prediction and Forecast 2025-2030

Eli Lilly's stock has seen remarkable growth recently, with a projected positive future driven by innovations and strategic investments.

Prediction: This Pharma Stock Will Be the Best Performer the Rest of 2024

Market pullbacks can make investors hesitant, but undervalued opportunities exist in the pharmaceutical and biotechnology sectors, with some stocks predicted to double in value.

Danish krone weakened by Novo Nordisk share price crash

Novo Nordisk's disappointing drug trial results caused a significant drop in its share price, impacting Denmark's economy and currency.

Pharma shares hit as Trump picks RFK Jr to lead health department

Trump's nomination of Robert F Kennedy Jr as Health Secretary has triggered panic selling among pharmaceutical investors.

S&P 500 and Dow notch new records

The U.S. stock market saw record highs due to tech and pharmaceutical stock increases.

Pfizer stock surges after activist takes $1 billion stake

Pfizer's stock peaked during the pandemic but has faced significant losses as demand for COVID-19 products faltered.

Eli Lilly (LLY) Stock Price Prediction and Forecast 2025-2030

Eli Lilly's stock has seen remarkable growth recently, with a projected positive future driven by innovations and strategic investments.

Prediction: This Pharma Stock Will Be the Best Performer the Rest of 2024

Market pullbacks can make investors hesitant, but undervalued opportunities exist in the pharmaceutical and biotechnology sectors, with some stocks predicted to double in value.

Danish krone weakened by Novo Nordisk share price crash

Novo Nordisk's disappointing drug trial results caused a significant drop in its share price, impacting Denmark's economy and currency.
morestock-market
#obesity-treatment

The FDA has ordered a phaseout of knockoffs for these blockbuster weight-loss drugs

The FDA's decision will phase out off-brand copies of obesity and diabetes drugs, affecting access and pricing for consumers.

Novo Nordisk's new weight-loss pill Amycretin beats Wegovy in early trial

Novo Nordisk's Amycretin shows promise for rapid weight loss, potentially surpassing current leading drugs like Wegovy and Ozempic.

Novo Nordisk's new weight-loss pill Amycretin beats Wegovy in early trial

Novo Nordisk's Amycretin shows greater weight loss potential than Wegovy in early trials, marking a significant development in obesity treatment.

New Amgen Drug MariTide Shows Promising Weight Loss in Early Data

Amgen's experimental obesity drug MariTide shows promise with an average weight loss of up to 20% over a year, pending further trials.

The FDA has ordered a phaseout of knockoffs for these blockbuster weight-loss drugs

The FDA's decision will phase out off-brand copies of obesity and diabetes drugs, affecting access and pricing for consumers.

Novo Nordisk's new weight-loss pill Amycretin beats Wegovy in early trial

Novo Nordisk's Amycretin shows promise for rapid weight loss, potentially surpassing current leading drugs like Wegovy and Ozempic.

Novo Nordisk's new weight-loss pill Amycretin beats Wegovy in early trial

Novo Nordisk's Amycretin shows greater weight loss potential than Wegovy in early trials, marking a significant development in obesity treatment.

New Amgen Drug MariTide Shows Promising Weight Loss in Early Data

Amgen's experimental obesity drug MariTide shows promise with an average weight loss of up to 20% over a year, pending further trials.
moreobesity-treatment
#public-health

A Rift in Trump World Over How to Make America Healthier

The debate on tackling obesity pits lifestyle changes against pharmaceutical solutions, reflecting differing views on health strategies.

The State That Chose to Cover Obesity Drugs for Its Poor, but Not Its Own Employees

North Carolina has begun covering new obesity medications for its poorest residents under Medicaid, highlighting a progressive approach to health equity.

RFK Jr will cut prescription drugs and increase weed and psychedelics access

Robert F. Kennedy Jr.'s potential appointment as HHS secretary raises concerns about undermining public health and trust in pharmaceuticals.

Huge demand for new obesity drugs risks overwhelming NHS, Streeting told

Unprecedented demand for obesity drugs is overwhelming NHS services, calling for urgent action.
Healthcare professionals demand a systematic overhaul to handle increasing treatment demand.

A Rift in Trump World Over How to Make America Healthier

The debate on tackling obesity pits lifestyle changes against pharmaceutical solutions, reflecting differing views on health strategies.

The State That Chose to Cover Obesity Drugs for Its Poor, but Not Its Own Employees

North Carolina has begun covering new obesity medications for its poorest residents under Medicaid, highlighting a progressive approach to health equity.

RFK Jr will cut prescription drugs and increase weed and psychedelics access

Robert F. Kennedy Jr.'s potential appointment as HHS secretary raises concerns about undermining public health and trust in pharmaceuticals.

Huge demand for new obesity drugs risks overwhelming NHS, Streeting told

Unprecedented demand for obesity drugs is overwhelming NHS services, calling for urgent action.
Healthcare professionals demand a systematic overhaul to handle increasing treatment demand.
morepublic-health
#innovation

Quantum Computing: Revolution in Solving Complex Problems

Quantum computing revolutionizes problem-solving by utilizing qubits for simultaneous calculations, vastly surpassing traditional computational methods.

Debunked: USPTO Findings Should End False Pharma Patent Narratives

The USPTO study disproves claims that pharmaceutical patents inhibit competition and reveals that such narratives have been manipulated by activists.

Quantum Computing: Revolution in Solving Complex Problems

Quantum computing revolutionizes problem-solving by utilizing qubits for simultaneous calculations, vastly surpassing traditional computational methods.

Debunked: USPTO Findings Should End False Pharma Patent Narratives

The USPTO study disproves claims that pharmaceutical patents inhibit competition and reveals that such narratives have been manipulated by activists.
moreinnovation

Structures and mechanism of condensation in nonribosomal peptide synthesis

NRPSs efficiently synthesize important pharmaceuticals through mechanism characterized by concerted reaction involving key catalytic sites.

10 Major New Jersey Industries to Consider if You're Working in or Moving to the State

New Jersey offers diverse job opportunities in pharmaceuticals, financial services, and technology, attracting homebuyers and renters with its robust economy.
#weight-loss

If they don't get care, they die': the woman who runs the world's largest kidney dialysis company

New weight-loss drugs could not only aid weight loss but also prolong the lives of chronic kidney disease patients.

Is Ozempic leaning into its viral weight loss reputation?

Ozempic shifted marketing towards weight loss despite lacking FDA approval.

10 Famous People Who Actually Admitted To Using Ozempic And 9 Who Flat-Out Denied It

Celebrities' use of Ozempic for weight loss affects access for diabetics.
Demand for weight loss drugs has led to shortages for diabetic patients.

If they don't get care, they die': the woman who runs the world's largest kidney dialysis company

New weight-loss drugs could not only aid weight loss but also prolong the lives of chronic kidney disease patients.

Is Ozempic leaning into its viral weight loss reputation?

Ozempic shifted marketing towards weight loss despite lacking FDA approval.

10 Famous People Who Actually Admitted To Using Ozempic And 9 Who Flat-Out Denied It

Celebrities' use of Ozempic for weight loss affects access for diabetics.
Demand for weight loss drugs has led to shortages for diabetic patients.
moreweight-loss
#healthcare

Mark Cuban says he's not going through a midlife crisis but would buy X and Fox News if he could

Mark Cuban's Cost Plus Drugs aims to disrupt the pharmaceutical industry by eliminating the middleman and offering lower prices on medications.

White House says deals struck to cut prices of popular Medicare drugs that cost $50 billion yearly

The Biden administration has negotiated lower prices for 10 high-cost Medicare drugs, potentially saving taxpayers and older Americans billions.

Popular cold medications don't work, say experts, as US considers ban

The efficacy of oral phenylephrine in cold medications is questioned, suggesting it may be time for bans on ineffective over-the-counter drugs.

Sanofi profit lifted by early vaccine sales, dupixent growth

Strong profit growth due to seasonal vaccines and Dupixent sales.
Sanofi increases annual profit forecast amid exclusive negotiations for consumer health unit.

Innovent Announces First-Time Inclusion of SINTBILO and New Indication for Olverembatinib in China's National Reimbursement Drug List

Innovent's SINTBILO® is officially included in the 2024 NRDL, marking a significant advancement in cholesterol management in China.

Roundtable held to lower drug costs, reform rules on middlemen

Malliotakis hosts a roundtable addressing high prescription drug costs and PBM practices impacting independent pharmacies.

Mark Cuban says he's not going through a midlife crisis but would buy X and Fox News if he could

Mark Cuban's Cost Plus Drugs aims to disrupt the pharmaceutical industry by eliminating the middleman and offering lower prices on medications.

White House says deals struck to cut prices of popular Medicare drugs that cost $50 billion yearly

The Biden administration has negotiated lower prices for 10 high-cost Medicare drugs, potentially saving taxpayers and older Americans billions.

Popular cold medications don't work, say experts, as US considers ban

The efficacy of oral phenylephrine in cold medications is questioned, suggesting it may be time for bans on ineffective over-the-counter drugs.

Sanofi profit lifted by early vaccine sales, dupixent growth

Strong profit growth due to seasonal vaccines and Dupixent sales.
Sanofi increases annual profit forecast amid exclusive negotiations for consumer health unit.

Innovent Announces First-Time Inclusion of SINTBILO and New Indication for Olverembatinib in China's National Reimbursement Drug List

Innovent's SINTBILO® is officially included in the 2024 NRDL, marking a significant advancement in cholesterol management in China.

Roundtable held to lower drug costs, reform rules on middlemen

Malliotakis hosts a roundtable addressing high prescription drug costs and PBM practices impacting independent pharmacies.
morehealthcare

Cassava Sciences update: SAVA stock price collapses after much-criticized Alzheimer's drug flops

Cassava Sciences' Alzheimer's drug simufilam failed its Phase 3 trials, leading to halted further trials and a significant plummet in stock value.
#obesity

Use of new diet drugs likely to mushroom- Harvard Gazette

Over half of U.S. adults qualify for semaglutide, highlighting a crucial need for equitable access to this high-cost medication.

Bernie Sanders Agrees with Elon Musk on Solving Obesity' With Government-Funded Ozempic

Bernie Sanders and Elon Musk agree on the need for affordable weight-loss drugs to combat obesity and related health issues.

Use of new diet drugs likely to mushroom- Harvard Gazette

Over half of U.S. adults qualify for semaglutide, highlighting a crucial need for equitable access to this high-cost medication.

Bernie Sanders Agrees with Elon Musk on Solving Obesity' With Government-Funded Ozempic

Bernie Sanders and Elon Musk agree on the need for affordable weight-loss drugs to combat obesity and related health issues.
moreobesity

Swiss pharma giant Novartis says 30 pipeline drugs with 'significant potential' will drive long-term growth

Novartis increased its mid-term sales growth forecast to 6%, expecting significant advances through pipeline assets and peak sales of key medications.

Will RFK Kibosh Ozempic?

Kennedy's nomination as HHS secretary reflects a shift in health policy towards deregulation and tackling chronic disease through food reform.

Why Takeda no longer has an 'IT department' as part of the drug maker's digital and data transformation

Takeda eliminated 'IT' to emphasize technology as a core business function and restructured for internal innovation and alignment with business goals.
#pfizer

Meet Jeff Smith, the hedge-fund investor taking on Pfizer

Starboard Value's $1 billion investment in Pfizer signals potential strategic changes, aiming to enhance operational efficiency and profitability.

Opinion: Pfizer (PFE) Stock Will Hit $22 Before It Hits $33 During Trump's Presidency

Trump's election win led to initial market growth, though pharmaceuticals may be adversely affected.

Meet Jeff Smith, the hedge-fund investor taking on Pfizer

Starboard Value's $1 billion investment in Pfizer signals potential strategic changes, aiming to enhance operational efficiency and profitability.

Opinion: Pfizer (PFE) Stock Will Hit $22 Before It Hits $33 During Trump's Presidency

Trump's election win led to initial market growth, though pharmaceuticals may be adversely affected.
morepfizer
#regulatory-compliance

AstraZeneca's drive for China dominance in focus as chief probed

AstraZeneca's growth in China faces scrutiny due to an investigation of aggressive sales tactics, impacting its reputation and future operations in the market.

Navigating the Complex World of Child Resistant Packaging in the Pharmaceutical Industry

Child-resistant packaging is critical for drug safety, particularly for protecting children, requiring a balance between adult accessibility and child safety.

AstraZeneca's drive for China dominance in focus as chief probed

AstraZeneca's growth in China faces scrutiny due to an investigation of aggressive sales tactics, impacting its reputation and future operations in the market.

Navigating the Complex World of Child Resistant Packaging in the Pharmaceutical Industry

Child-resistant packaging is critical for drug safety, particularly for protecting children, requiring a balance between adult accessibility and child safety.
moreregulatory-compliance

British pharma giant GSK reports a Q3 loss due to Zantac cancer lawsuits

GSK reported a £58 million loss due to Zantac settlement, contrasting with a £1.5 billion profit last year.
#medical-innovation

Breakthrough by William Pao review the drugs do work

Creative innovation in drug development becomes a transformative force in medicine, driven by personal dedication and often serendipitous discoveries.

An automated approach to saving lives

Cellares aims to enhance access to critical cell therapies through innovative manufacturing approaches.

Breakthrough by William Pao review the drugs do work

Creative innovation in drug development becomes a transformative force in medicine, driven by personal dedication and often serendipitous discoveries.

An automated approach to saving lives

Cellares aims to enhance access to critical cell therapies through innovative manufacturing approaches.
moremedical-innovation

The Medicines We Take Don't All Break Down In Our Bodies - They End Up Here Instead

Modern medicines pose a significant threat to ecosystems due to pharmaceuticals contaminating waterways and harming wildlife, necessitating urgent changes in drug design.

Ask Ugly: I was prescribed medicine for a zit. Should I take it?

Struggles with acne often intertwine with societal beauty standards, impacting mental health and self-esteem.
The author highlights the emotional and psychological challenges of dealing with severe acne and beauty culture.
#mark-cuban

Mark Cuban on Kamala Harris, Cost Plus Drugs, and the Dallas Mavericks

Mark Cuban discusses his transition from business to pharmaceuticals and the challenges of raising children as a billionaire.

Mark Cuban is lauding Kamala Harris for joining him in his big fight to lower prescription drug prices

Kamala Harris aims to lower drug prices by taking on pharmacy middlemen.

Mark Cuban on Kamala Harris, Cost Plus Drugs, and the Dallas Mavericks

Mark Cuban discusses his transition from business to pharmaceuticals and the challenges of raising children as a billionaire.

Mark Cuban is lauding Kamala Harris for joining him in his big fight to lower prescription drug prices

Kamala Harris aims to lower drug prices by taking on pharmacy middlemen.
moremark-cuban
#drug-discovery

AI Model Predicts Dual Target Drugs

AI is transforming biotechnology and pharmaceuticals by enabling the design of drugs that target multiple diseases simultaneously.

Marie Curie Office Building / Proof of the Sum

Pivot Park is a hub for open innovation in drug discovery, fostering collaboration and development in the pharmaceutical field.

AI Model Predicts Dual Target Drugs

AI is transforming biotechnology and pharmaceuticals by enabling the design of drugs that target multiple diseases simultaneously.

Marie Curie Office Building / Proof of the Sum

Pivot Park is a hub for open innovation in drug discovery, fostering collaboration and development in the pharmaceutical field.
moredrug-discovery
#glp-1-medications

The Crackdown on Compounded GLP-1 Meds Has Begun

Eli Lilly is intensifying legal actions against compounded GLP-1 medications amid ongoing product shortages.

A Major GLP-1 Drug Shortage Is Over. Some Patients Aren't Celebrating

The end of tirzepatide shortage brings uncertainty for patients reliant on compounded versions of the drug.
Patients fear losing access to effective medication due to shortages, complicating the availability situation.

The Crackdown on Compounded GLP-1 Meds Has Begun

Eli Lilly is intensifying legal actions against compounded GLP-1 medications amid ongoing product shortages.

A Major GLP-1 Drug Shortage Is Over. Some Patients Aren't Celebrating

The end of tirzepatide shortage brings uncertainty for patients reliant on compounded versions of the drug.
Patients fear losing access to effective medication due to shortages, complicating the availability situation.
moreglp-1-medications

En Banc Review in Allergan: Questioning the Federal Circuit's New ODP Safe Harbor

Sun Pharma's en banc petition contests a controversial Federal Circuit decision regarding obviousness-type double patenting and written description support.
The Allergan decision may set problematic precedents for patent families and disclosure requirements.

How Cannabis and Opium Poppies Became National Security Issues

Bright Green aims to grow cannabis and opium poppies for pharmaceutical production, focusing on scientific research rather than retail marijuana.

Novo Nordisk's market value of $570 billion is more than Denmark's annual GDP

Danish PM defends economy's resilience amid concerns of over-reliance on Novo Nordisk.

People Are Revealing The Worst Mistakes They've Ever Made During Job Interviews

Asking pointed questions during an interview can reveal critical insights about a company's product and strategy.

Aging is the inflation of life. An emerging crop of longevity biotech companies needs investment to beat it

Healthy lifestyle can prolong life but can't prevent aging; advanced biotechnology may offer new solutions for longevity.
The field of longevity biotechnology is developing, aimed at combatting aging more effectively than traditional health measures.
#fda

FDA drug-plant inspections still haven't recovered from the pandemic, AP reports

The FDA has not inspected around 2,000 drug manufacturing plants since before the pandemic, presenting significant safety risks.

Nearly 2,000 drug manufacturing plants are overdue for FDA inspections after COVID delays, AP finds

FDA inspections of pharmaceutical plants have not recovered from pandemic delays, risking drug safety for millions of Americans.

FDA drug-plant inspections still haven't recovered from the pandemic, AP reports

The FDA has not inspected around 2,000 drug manufacturing plants since before the pandemic, presenting significant safety risks.

Nearly 2,000 drug manufacturing plants are overdue for FDA inspections after COVID delays, AP finds

FDA inspections of pharmaceutical plants have not recovered from pandemic delays, risking drug safety for millions of Americans.
morefda

China detains five AstraZeneca staff over data privacy and import breaches'

AstraZeneca employees are under investigation for potential data privacy breaches and the import of unauthorized cancer medications in China.

ServiceNow says GenAI has its benefits

ServiceNow assures investors that while returns from GenAI are not immediate, significant long-term benefits may reshape industries.
Generative AI's potential in pharma includes reducing product development timelines, leading to substantial cost savings.

A Popular Weight Loss Drug Is Getting a Price Cut

A novel marketplace for compounded medications has emerged due to high demand and limited supply, directly impacting access to weight-loss drugs.

Prozac in waterways is changing how fish behave, research finds

Prozac contamination in waterways disrupts fish behaviour and health, threatening their survival.

Other Barks & Bites for Friday, August 23: Music Publishers Petition Supreme Court to Review Overturned $1 Billion Copyright Infringement Judgment; Nike Continues Trademark Infringement Lawsuit Against 'Shoe Surgeon'

Vice President Kamala Harris advocates for patent reform concerning high pharmaceutical prices, sparking viral attention.
A tattoo artist's copyright infringement case involving LeBron James tattoos is dismissed, highlighting image rights implications.

Novo Nordisk's weight-loss drugs and Bavarian Nordic's mpox vaccine help fatten up the Danish economy

Denmark's economy is significantly influenced by its pharmaceutical industry, highlighting both growth potential and volatility.

Ozempic knockoffs flood US market thanks to blind spot' in FDA rules

The obscurity of a federal statute is enabling US pharmacies to flood the market with unvetted knockoffs of popular weight-loss drug Ozempic.

Hims & Hers to sell inexpensive Ozempic alternative

Online pharmaceutical brands Hims & Hers are introducing a cost-effective weight-loss drug with semaglutide.

When copay assistance backfires on patients

Employers may stop counting copay assistance from drugmakers towards annual deductibles, leading patients to pay more out-of-pocket.
Patients can face unexpected high bills for medications when insurers or employers implement copay accumulator programs.

Tick-killing pill shows promising results in human trial

A human pill is being developed for Lyme disease prevention which can kill ticks within 24 hours and provide protection for up to 30 days.
from MobileAppAaily
11 months ago

6 Predictions Of 2024 That Will Put AI To Reality Check Test

AI's impact in 2023 fell short of expectations
AI will bloom in tech, banking, pharmaceuticals, and education in 2024

Merck to Buy Harpoon Therapeutics for $680 Million

Merck & Co. is acquiring Harpoon Therapeutics for $680 million in cash.
The acquisition price of $23 per share is more than double Harpoon's closing price of $10.55.
[ Load more ]